B NERSTROM
Overview
Explore the profile of B NERSTROM including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borre M, Stausbol-Gron B, NERSTROM B, Overgaard J
Prostate Cancer Prostatic Dis
. 2002 Dec;
1(5):268-275.
PMID: 12496887
The prognostic value of BCL-2 expression, solely and combined with Ki-67 expression, was determined in prostate cancer patients followed expectantly. Furthermore, associations with well established prognostic markers were tested. Formalin...
2.
Borre M, NERSTROM B, Overgaard J
Clin Cancer Res
. 2000 May;
6(5):1882-90.
PMID: 10815911
Tumor growth is dependent on angiogenesis, which is thought to be controlled by angiogenic factors. Therefore, the immunoreactivity of the angiogenic cytokine vascular endothelial growth factor (VEGF) was semiquantitatively scored...
3.
Zubac D, Malmfred S, NERSTROM B
Scand J Urol Nephrol
. 2000 Apr;
34(1):72-4.
PMID: 10757276
No abstract available.
4.
Borre M, Offersen I, NERSTROM B, Overgaard J
Ugeskr Laeger
. 1999 Jul;
161(25):3832-6.
PMID: 10412301
Angiogenesis, the formation of new blood vessels, has been suggested to provide important prognostic information in prostate cancer. The aim of this study was to investigate, whether microvessel density (MVD)...
5.
Langkilde N, Pless T, Lundbeck F, NERSTROM B
Scand J Urol Nephrol
. 1999 Jun;
33(2):100-3.
PMID: 10360449
Objective: Vesicovaginal fistulae in the western world generally occur as complications to pelvic surgery or radiation therapy of pelvic cancers. We have reviewed our results of vesicovaginal fistula closure procedures...
6.
Borre M, Offersen B, NERSTROM B, Overgaard J
Br J Cancer
. 1998 Oct;
78(7):940-4.
PMID: 9764587
The biological potential of prostate cancer is highly variable and cannot be satisfactorily predicted by histopathological criteria alone. Angiogenesis, the formation of new blood vessels, has been suggested to provide...
7.
Borre M, Hoyer M, NERSTROM B, Overgaard J
Prostate
. 1998 Aug;
36(4):244-9.
PMID: 9719024
Background: The optimal approach to diagnosis and treatment of localized prostate cancer remains controversial. Deoxyribonucleic acid (DNA) ploidy has been suggested as an important predictor for outcome in prostate cancer....
8.
Borre M, Bentzen S, NERSTROM B, Overgaard J
J Urol
. 1998 Apr;
159(5):1609-14.
PMID: 9554364
Purpose: Prostate cancers have different biological potentials, and aggressive tumors are difficult to identify when still localized. Tumor cell proliferation determined by MIB-1 expression has been suggested as an important...
9.
Borre M, Hoyer M, Sorensen F, NERSTROM B, Overgaard J
APMIS
. 1998 Apr;
106(3):389-95.
PMID: 9548428
Large variability in the biological behavior of prostate cancer makes prognostic markers important. The extent of tumor cell proliferation has been suggested as an important predictor of clinical outcome. Fifty-five...
10.
Borre M, NERSTROM B, Overgaard J
Cancer
. 1997 Nov;
80(5):917-28.
PMID: 9307192
Background: Prostate carcinoma is one of the most commonly diagnosed cancers among Western males. In Denmark, the traditional therapeutic approach to prostate carcinoma regardless of tumor stage has been limited...